These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 19889051

  • 1. Pseudolymphomatous reaction to varicella zoster virus vaccination: role of viral in situ hybridization.
    Porto DA, Comfere NI, Myers LM, Abbott JJ.
    J Cutan Pathol; 2010 Oct; 37(10):1098-102. PubMed ID: 19889051
    [Abstract] [Full Text] [Related]

  • 2. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D, Jovanović J, Hrnjaković-Cvjetković I, Brkić S, Bogdanović M.
    Med Pregl; 1999 Oct; 52(3-5):125-8. PubMed ID: 10518396
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Detection of varicella zoster virus DNA and viral antigen in human eyes after herpes zoster ophthalmicus.
    Wenkel H, Rummelt V, Fleckenstein B, Naumann GO.
    Ophthalmology; 1998 Jul; 105(7):1323-30. PubMed ID: 9663241
    [Abstract] [Full Text] [Related]

  • 7. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
    Kazakov DV, Belousova IE, Kacerovska D, Sima R, Vanecek T, Vazmitel M, Pizinger K, Michal M.
    Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
    [Abstract] [Full Text] [Related]

  • 8. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
    Lu PJ, Euler GL, Jumaan AO, Harpaz R.
    Vaccine; 2009 Feb 05; 27(6):882-7. PubMed ID: 19071175
    [Abstract] [Full Text] [Related]

  • 9. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G.
    Expert Rev Vaccines; 2010 Mar 05; 9(3 Suppl):31-5. PubMed ID: 20192716
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Latency and reactivation of varicella zoster virus infections.
    Dueland AN.
    Scand J Infect Dis Suppl; 1996 Mar 05; 100():46-50. PubMed ID: 9163025
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Varicella-zoster-virus folliculitis promoted clonal cutaneous lymphoid hyperplasia.
    Aram G, Rohwedder A, Nazeer T, Shoss R, Fisher A, Carlson JA.
    Am J Dermatopathol; 2005 Oct 05; 27(5):411-7. PubMed ID: 16148411
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of age.
    Tyring SK, Diaz-Mitoma F, Padget LG, Nunez M, Poland G, Cassidy WM, Bundick ND, Li J, Chan IS, Stek JE, Annunziato PW, Protocol 009 Study Group.
    Vaccine; 2007 Feb 26; 25(10):1877-83. PubMed ID: 17227688
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.